Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
12.33
-0.17 (-1.36%)
At close: Feb 19, 2026, 4:00 PM EST
12.43
+0.10 (0.81%)
After-hours: Feb 19, 2026, 4:10 PM EST

Tenax Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
99.3794.859.792.125.586.25
Short-Term Investments
-----0.46
Cash & Short-Term Investments
99.3794.859.792.125.586.71
Cash Growth
1.08%868.66%361.09%-61.97%-16.82%24.32%
Prepaid Expenses
3.441.771.640.740.110.08
Other Current Assets
-0.060.250.35--
Total Current Assets
102.8196.6911.683.215.696.8
Property, Plant & Equipment
---0.190.290.06
Other Long-Term Assets
--00.010.010.01
Total Assets
102.8196.6911.693.45.996.87
Accounts Payable
5.613.162.070.450.860.76
Accrued Expenses
0.991.541.010.660.61.18
Short-Term Debt
--0.50.62--
Current Portion of Long-Term Debt
-----0.12
Current Portion of Leases
---0.120.110.06
Total Current Liabilities
6.64.693.591.851.562.12
Long-Term Debt
-----0.12
Long-Term Leases
---0.060.18-
Total Liabilities
6.64.693.591.911.752.24
Common Stock
0--000
Additional Paid-In Capital
448.12406.85305.35291.03282.74250.64
Retained Earnings
-351.91-314.86-297.25-289.54-278.49-246.02
Comprehensive Income & Other
------0
Total Common Equity
96.2191.998.11.494.244.63
Shareholders' Equity
96.2191.998.11.494.244.63
Total Liabilities & Equity
102.8196.6911.693.45.996.87
Total Debt
--0.50.810.290.31
Net Cash (Debt)
99.3794.859.291.325.296.41
Net Cash Growth
1.08%920.89%606.12%-75.14%-17.40%22.56%
Net Cash Per Share
2.616.2137.4071.55411.57-
Filing Date Shares Outstanding
40.5735.851.960.350.02-
Total Common Shares Outstanding
40.2335.30.30.030.02-
Working Capital
96.2191.998.11.364.134.68
Book Value Per Share
2.392.6127.1552.11269.43-
Tangible Book Value
96.2191.998.11.494.244.63
Tangible Book Value Per Share
2.392.6127.1552.11269.43-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q